A double-blinded, randomized controlled trial on the effect of traditional Chinese medicine formula Shoutai pill on treating threathened miscarriage

Clinical study on the effect of classic formula Shoutai pill on treating threathened miscarriage

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043700

Enrollment

Unknown

Registered

2021-02-27

Start date

2021-03-20

Completion date

Unknown

Last updated

2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

threatened miscarriage

Interventions

treatment group:Shoutai pill

Control group:placebo

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for threatened miscarrige; 2. Meet within 20 weeks of pregnancy; 3. Meet the age of 20-40 years old; 4. Agree to participate in this clinical trial study and have good compliance.

Exclusion criteria

Exclusion criteria: 1. Complicated with uterine leiomyoma,adenomyosis,uterine benign and malignant tumor,reproductive tract malformation; 2. Complicated with serious medical diseases such as heart disease, abnormal liver and kidney function, hematological disease, etc.; 3. Complicated with abnormal endocrine function such as thyroid, adrenal gland and pituitary gland; 4. Unable to cooperate with researchers, such as mental and intellectual abnormalities; 5. Have taken other fetus protection drugs recently; 6. Have bad habits such as smoking and drinking, long-term exposure to radioactive environment or exposure to certain chemicals (pesticides, lead, arsenic, mercury, etc.).

Design outcomes

Primary

Measure	Time frame
Estradiol;Progesterone;ß-hCG;	—

Countries

China

Contacts

Public ContactZhang Ning

ning_zhang1975@163.com+86 18766101739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026